Pediatric Speech Therapy Session Frequency and Speech Outcomes
NCT ID: NCT05900180
Last Updated: 2025-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
39 participants
INTERVENTIONAL
2023-01-01
2027-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correcting Residual Errors With Spectral, Ultrasound, Traditional Speech Therapy
NCT03737318
Determining Optimal Treatment Intensity for Children With Language Impairment
NCT04501536
Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
NCT06181149
Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)
NCT03015272
The Effect of Prior Learning on Word Learning
NCT05921188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Every-other-week therapy with home programming
Receipt of standard speech therapy care (every-other-week) for 8.0 sessions
Speech Therapy
Delivery of speech therapy services
Weekly therapy with home programming
Receipt of speech therapy care (every week) for 8.0 sessions
Speech Therapy
Delivery of speech therapy services
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Speech Therapy
Delivery of speech therapy services
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients eligible for speech therapy at Connecticut Children's (qualify for receptive, expressive language and/or articulation therapy)
* Diagnosis of communication disorder.ICD-10 codes will be utilized pertaining to expressive, receptive language and articulation disorders (ICD-10 code specific to patient: F80.0, F80.1, F80.2, F80.4, F80.9, R47.89, R41.841)
* Patient recommended for individual (i.e. not group) treatment
* 18 months to 16 years of age
* Completed 1 plan of care (POC) with a duration of 8 sessions
* Attended at least 80% of scheduled visits during their plan of care period (still completing 8 sessions of therapy, may have extended time to completion).
* Services for a full 8-session plan of care.
Exclusion Criteria
* Patient unable to complete standardized tests (EOWPVT-4, ROWPVT-4, GFTA-3, REEL-4)
* Patients in group speech therapy
* Patients younger than 18 months or older than 16 years of age
* Not willing to complete a full POC (8 sessions)
* Unable/unwilling to attend 80% of scheduled visits
18 Months
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Connecticut Children's Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virginia Van Epps, M.Ed.
Role: PRINCIPAL_INVESTIGATOR
Connecticut Children's Medical Center
Mary Dortenzio, MS
Role: STUDY_DIRECTOR
Connecticut Children's Medical Center
Jodi Urzua, MS
Role: STUDY_DIRECTOR
Connecticut Children's Medical Center
Emma Mendillo, MA
Role: STUDY_DIRECTOR
Connecticut Children's Medical Center
Morgan Daur-Schierholz, MS
Role: STUDY_DIRECTOR
Connecticut Children's Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Connecticut Children's Medical Center
Hartford, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.